Trial intelligence / Profile preview

Hormone replacement therapy for sleep and quality of life in menopausal women with fibromyalgia

RBR-24bbzsPhase 4Recruiting

Sponsor
Hospital de Clínicas da Universidade Federal do Paraná
Start
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of estradiol and progesterone in menopause, fibromyalgia (FM) and sleep disorder, sponsored by Hospital de Clínicas da Universidade Federal do Paraná. Started Aug 2018; status: recruiting.

02

Drugs

estradiolprogesterone
03

Conditions

menopausefibromyalgia (FM)sleep disorder

Beyond the preview

Go deeper on RBR-24bbzs.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-24bbzs.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call